In this report, we confirm that Pyk2 is targeted by miR-23b and demonstrate that increased expression of miR-23b inhibits glioma cell migration in vitro and invasion ex vivo while knockdown of miR-23b stimulates glioma cell migration. Here, PTK2B is linked to glioma.